The medical community is not a monolithic entity, but a complex network of relationships and influences. While national scientific key opinion leaders (KOL) and high-volume prescribers are often the focus of pharma companies’ engagement strategies, they may not be the most effective channels to drive treatment and behavioral change.
Key takeaways:
- Identify the hidden leaders in the medical community using data-driven methods and social network analysis.
- Understand the role and impact of hidden leaders in influencing treatment decisions and outcomes.
- Develop and implement a tailored engagement strategy for hidden leaders that leverages their relationships and connections.
- Deliver trusted medical evidence and right stakeholder dialogue to improve patient outcomes and satisfaction.
Speakers:
Christine Aber
Assoc. Director, Thought Leader Engagement – U.S. Medical Affairs, IQVIA
Tim Weckwerth
Principal, Thought Leader Engagement Center of Excellence, IQVIA
Deryk David
Vice President, Intercept Pharmaceuticals
